These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 5931752)

  • 1. Radiation-induced changes in the properdin system of the dog and a critical analysis of the general problem.
    Michaelson SM; Shively JN; Haydock IC
    Radiat Res; 1966 May; 28(1):60-70. PubMed ID: 5931752
    [No Abstract]   [Full Text] [Related]  

  • 2. [Microchemical method for the determination of properdin].
    Pfordte K
    Z Gesamte Exp Med Einschl Exp Chir; 1966; 140(4):294-302. PubMed ID: 5991291
    [No Abstract]   [Full Text] [Related]  

  • 3. Anaphylatoxin formation by contact activation of plasma. II. Implication of properdin and an unknown plasma factor in activation by zymosan.
    Brade V; Vogt W
    Eur J Immunol; 1971 Aug; 1(4):295-300. PubMed ID: 4945686
    [No Abstract]   [Full Text] [Related]  

  • 4. Kinetic studies of the formation of the properdin system enzymes on zymosan: evidence that nascent C3b controls the rate of assembly.
    Nicholson A; Brade V; Lee GD; Shin HS; Mayer MM
    J Immunol; 1974 Mar; 112(3):1115-23. PubMed ID: 4811964
    [No Abstract]   [Full Text] [Related]  

  • 5. [Properdin research. 1. Review of the properdin system and its problems; determination possibilities, assay of sera with high titer levels].
    Zimmermann G
    Arch Exp Veterinarmed; 1972; 26(2):221-46. PubMed ID: 4562974
    [No Abstract]   [Full Text] [Related]  

  • 6. [ULTRACENTRIFUGE STUDIES ON PROPERDIN SERA OF ZYMOSAN-VACCINATED CATTLE, RABBITS, GUINEA PIGS, RATS AND MICE AND ON BOVINE PROPERDIN SERUM FRACTIONS].
    ZIMMERMANN G; KRUEGER K
    Acta Biol Med Ger; 1963; 11():902-17. PubMed ID: 14121884
    [No Abstract]   [Full Text] [Related]  

  • 7. The rabbit properdin system: I. Identification of a new factor and purification of rabbit properdin.
    Naff GB; Hedrick SW; Ratnoff WD; Novak MA; Smith MC; Steiner C; Todd EW
    J Immunol; 1980 Jun; 124(6):2625-31. PubMed ID: 6900053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formation of the C3-cleaving properdin enzyme on zymosan. Demonstration that factor D is replaceable by proteolytic enzymes.
    Brade V; Nicholson A; Bitter-Suermann D; Hadding U
    J Immunol; 1974 Dec; 113(6):1735-43. PubMed ID: 4279261
    [No Abstract]   [Full Text] [Related]  

  • 9. The reaction of zymosan with the properdin system: isolation of purified factor D from guinea pig serum and study of its reaction characteristics.
    Brade V; Nicholson A; Lee GD; Mayer MM
    J Immunol; 1974 May; 112(5):1845-54. PubMed ID: 4818461
    [No Abstract]   [Full Text] [Related]  

  • 10. Some observations on the properdin system. 8. Properdin and its relation to blood constituents of human and some laboratory animals.
    Majumdar AC; Datta TK; Sarma AK; Ray MK
    J Indian Med Assoc; 1972 Nov; 59(10):428-31. PubMed ID: 4658784
    [No Abstract]   [Full Text] [Related]  

  • 11. Alterations in serum lysozyme and properdin titers of mice following x-irradiation or treatment with zymosan or endotoxin.
    HOOK WA; CAREY WF; MUSCHEL LH
    J Immunol; 1960 Jun; 84():569-75. PubMed ID: 14402997
    [No Abstract]   [Full Text] [Related]  

  • 12. SOME RES EFFECTS INFLUENCING RADIATION SURVIVAL TIME.
    SZANTO A
    Acta Unio Int Contra Cancrum; 1964; 20():1233-5. PubMed ID: 14274743
    [No Abstract]   [Full Text] [Related]  

  • 13. General pharmacology of the new antimuscarinic compound vamicamide.
    Yamamoto T; Honbo T; Tokoro K; Kojimoto Y; Kodama R; Ohtsuka M; Shimomura K
    Arzneimittelforschung; 1995 Dec; 45(12):1274-84. PubMed ID: 8595084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of non-specific stimulation with zymosan on serum properdin level in patients with neoplasms].
    Dobrek Z; Majewski S; Maciejewski B
    Pol Tyg Lek; 1972 Jul; 27(24):905-8. PubMed ID: 5040537
    [No Abstract]   [Full Text] [Related]  

  • 15. [PROPERDIN AND ANAPHYLATOXIN].
    WILLEMS G
    Rev Immunol Ther Antimicrob; 1963; 27():285-90. PubMed ID: 14111198
    [No Abstract]   [Full Text] [Related]  

  • 16. EFFECT OF ULTRAVIOLET IRRADIATION ON THE PROPERDIN LEVEL OF PIGS' SERA IN VITRO.
    SZEMERE G
    Med Pharmacol Exp Int J Exp Med; 1965; 12():366-72. PubMed ID: 14332240
    [No Abstract]   [Full Text] [Related]  

  • 17. [Methodological bases for animal experiments with the use of ionizing radiation].
    Gajewski AK; Rózycki Z
    Rocz Panstw Zakl Hig; 1974; 25(5):583-95. PubMed ID: 4420848
    [No Abstract]   [Full Text] [Related]  

  • 18. [Fibrinolysis and factors of aspecific immunity. Preliminary note].
    Ferrauto A; Giuffrida G; Terranova R
    Boll Soc Ital Biol Sper; 1965 Dec; 41(24):1488-91. PubMed ID: 5878160
    [No Abstract]   [Full Text] [Related]  

  • 19. [Interrelations of zymosan, properdin & tumors. III. Behavior of the properdin level in benzopyrene sarcoma-bearing rats treated with zymosan].
    FUMAROLA D; MODICA F
    Tumori; 1959; 45(1):46-53. PubMed ID: 13659609
    [No Abstract]   [Full Text] [Related]  

  • 20. General pharmacology of recombinant human basic fibroblast growth factor.
    Okumura M; Yajima M; Nishimura T; Ikeda H; Nishimori T
    Arzneimittelforschung; 1996 Jul; 46(7):727-39. PubMed ID: 8842346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.